Crinetics Pharmaceuticals Inc (CRNX)
44.52
+0.00%
Crinetics Pharmaceuticals Inc (CRNX) is currently trading at $44.52. This represents a gain of 0% from the previous session. With a market capitalization of $4.22B, CRNX is a key component of the Health Care sector. Investors looking to trade CRNX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade CRNX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Crinetics Pharmaceuticals Inc (CRNX) shows a bullish trend. Analysts are watching the 0.00 level closely.
Fundamentals
Mkt Cap4.22B
P/E Ratio0.0000
Volume79
60-Day Technical Chart
Advanced Charting
Need more indicators for CRNX? Use the world's #1 platform.
Open CRNX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $45
| Metric |
CRNX +0.00% |
INTC +0.00% |
PYPL +0.00% |
CNC +0.00% |
|---|---|---|---|---|
| Price | $44.52 | $46.12 | $47.02 | $42.37 |
| Mkt Cap | $4.22B | $230.37B | $43.29B | $20.84B |
| - | View → | View → | View → |
Latest Headlines
Is Crinetics Pharmaceuticals (CRNX) Offering Value After Recent Share Price Pullback
Yahoo Finance • Feb 25, 2026
Crinetics plans March appearances at TD Cowen and Leerink events
Stock Titan • Feb 5, 2026
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)
TechStock² • Dec 18, 2025
Why Crinetics Pharmaceuticals (CRNX) Is Up 18.2% After Equity Raise and PALSONIFY, Atumelnant Updates
simplywall.st • Jan 14, 2026
Interesting CRNX Put And Call Options For November 21st
Nasdaq • Sep 19, 2025
● Gemini Agentic AI Analyst Insight for CRNX
Market Education
- These Whales are taking all the Ape money - aka Large Fund Mgmt Companies Jul 17, 2023
- Trump’s New Tariffs Could Push Up Kitchen Renovation Costs Sep 26, 2025
- Canada Pension Plan - Top Stocks Nov 20, 2023
External Research